These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33060787)

  • 21. Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction.
    Gur S; Kadowitz PJ; Hellstrom WJ
    Curr Pharm Des; 2010 May; 16(14):1619-33. PubMed ID: 20201788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons.
    Hepp R; Tricoire L; Hu E; Gervasi N; Paupardin-Tritsch D; Lambolez B; Vincent P
    J Neurochem; 2007 Sep; 102(6):1875-1886. PubMed ID: 17561940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zhenwu decoction ameliorates cardiac hypertrophy through activating sGC (soluble guanylate cyclase) - cGMP (cyclic guanosine monophosphate) - PKG (protein kinase G) pathway.
    Chen L; Zhou X; Deng Y; Yang Y; Chen X; Chen Q; Liu Y; Fu X; Kwan HY; You Y; Jin W; Zhao X
    J Ethnopharmacol; 2023 Jan; 300():115705. PubMed ID: 36099983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A primer for measuring cGMP signaling and cGMP-mediated vascular relaxation.
    Straub AC; Beuve A
    Nitric Oxide; 2021 Dec; 117():40-45. PubMed ID: 34601102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications.
    Kreisel W; Lazaro A; Trebicka J; Grosse Perdekamp M; Schmitt-Graeff A; Deibert P
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potential.
    Buys ES; Zimmer DP; Chickering J; Graul R; Chien YT; Profy A; Hadcock JR; Masferrer JL; Milne GT
    Nitric Oxide; 2018 Aug; 78():72-80. PubMed ID: 29859918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Endothelium-Dependent Nitric Oxide-cGMP Pathway.
    Mónica FZ; Bian K; Murad F
    Adv Pharmacol; 2016; 77():1-27. PubMed ID: 27451093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.
    Bellamy TC; Wood J; Goodwin DA; Garthwaite J
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2928-33. PubMed ID: 10717006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and regulation of soluble guanylate cyclase.
    Derbyshire ER; Marletta MA
    Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and development.
    Friebe A; Sandner P; Schmidtko A
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):287-302. PubMed ID: 31853617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation.
    Wittenborn EC; Marletta MA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrauterine growth restriction is associated with sex-specific alterations in the nitric oxide/cyclic GMP relaxing pathway in the human umbilical vein.
    Beaumann M; Delhaes F; Menétrey S; Joye S; Vial Y; Baud D; Magaly JG; Tolsa JF; Peyter AC
    Placenta; 2020 Apr; 93():83-93. PubMed ID: 32250743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report.
    Friebe A; Kraehling JR; Russwurm M; Sandner P; Schmidtko A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1669-1686. PubMed ID: 37079081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sGC-cGMP Signaling Pathway as a Potential Therapeutic Target in Doxorubicin-Induced Heart Failure: A Narrative Review.
    Cho H; Zhao XX; Lee S; Woo JS; Song MY; Cheng XW; Lee KH; Kim W
    Am J Cardiovasc Drugs; 2022 Mar; 22(2):117-125. PubMed ID: 34151411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension.
    Mergia E; Stegbauer J
    Curr Hypertens Rep; 2016 Apr; 18(5):39. PubMed ID: 27079836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR; Schittl J; Fischmeister R
    Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension.
    Chen CN; Watson G; Zhao L
    Vascul Pharmacol; 2013 Mar; 58(3):211-8. PubMed ID: 22982057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of cGMP in heart failure: a new therapeutic paradigm.
    Boerrigter G; Lapp H; Burnett JC
    Handb Exp Pharmacol; 2009; (191):485-506. PubMed ID: 19089342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
    Hussain MB; Hobbs AJ; MacAllister RJ
    Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.